Investment Research Consultations
Institutional investors, hedge funds, and private equity firms frequently seek expert consultations to validate investment theses, assess competitive dynamics, and understand industry trends. Dr. Kurr provides insight on pharma commercial model transformation, content supply chain economics, omnichannel strategy maturity, CDMO and outsourcing trends, and the competitive landscape across Boehringer Ingelheim, Novartis, and the broader pharma sector. His perspective is uniquely valuable because it combines deep insider knowledge with current advisory market activity.
Corporate Strategy Consultations
Corporations evaluating strategic decisions - entering new markets, restructuring operations, building service organizations, or evaluating partnership strategies - benefit from rapid access to practitioners who have faced similar challenges. Dr. Kurr provides targeted, high-impact consultations on operating model design, cooperation management, content operations, and organizational transformation - distilling 20+ years of experience into actionable guidance within a single call or short engagement.
Premium Expert Network Platforms
Dr. Kurr is available through leading expert networks including GLG (Gerson Lehrman Group), AlphaSights, Guidepoint, Third Bridge, Tegus, Prosapient, and Dialectica. These platforms provide structured, compliance-screened engagements that connect his expertise with the specific questions decision-makers need answered - efficiently and at premium rates reflecting the depth and currency of his knowledge.
Topics of Expertise
Key topics Dr. Kurr is sought for include: pharma commercial model transformation, content supply chain design and optimization, omnichannel HCP engagement strategy, global business services (GBS) design, cooperation management and strategic alliances, digital factory and AI strategy in regulated industries, automotive and manufacturing operating model transformation, and organizational design for scale. Each topic is backed by hands-on experience - not just advisory perspective.